ANIP: מכפיל P/S ANI Pharma

ANI Pharmaceuticals is implementing packaging and encapsulation automation to reduce personnel costs. The company also utilizes third-party contractors for product manufacturing and pharmacy distribution. The current P/S multiple, with GURU.Markets data illustrated on this chart, is characterized by 1.60 setting the current value of the metric. The firm successfully combines the production of generics with the sale of profitable orphan drugs.

For ANI Pharmaceuticals (ANIP), which combines in-house capacities with GMP-standard outsourced production, the P/S multiple serves as a key tool for evaluating revenue generation efficiency. By analyzing the current P/S valuation, an investor compares market capitalization with actual sales volume, allowing them to filter out speculative noise and determine the fair value of the business relative to its operational scale.